开拓药业-B今日盘中股价大幅上涨11.81%，引起了市场的广泛关注。
消息面上，公司此前发布公告称，自2026年开年以来，其B2C和B2B销售业务实现快速稳定增长。根据初步统计，本年度累计销售收入已超过2025年全年总额。
具体数据显示，公司本年度销售收入已达约人民币3400万元，超过去年全年的3268万元，并有望完成全年超过人民币1.5亿元的目标。增长主要得益于B2C国内电商销售同比激增25倍，以及海外电商销售同比增长150%。公司自播业务启动后持续增长，本月平均日销售额近人民币10万元，并创下单日成交总额人民币40万元的纪录。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.